Ireland trumpets Pfizer biotech facility

Pfizer is keeping mum about a biologics facility it's preparing to build in Ireland, but no one else appears to be. Jacobs Engineering, which Pfizer tapped to perform pre-construction services at the site, trumpeted its selection in a press release. And the Irish newspapers, encouraged by the prospect of 100 new high-tech jobs, are all over the story.

"Cork County Council recently granted planning permission for the facility,": writes the Irish Examiner, "and if the plan is approved by Pfizer construction should begin immediately, with the facility expected to be completed by early 2009."

The drug maker says that the proposed biologics facility still hasn't received final, internal approval, and that hiring Jacobs was only a necessary step in its decision-making process. A final determination is expected in October.

- check out the press release from Jacobs
- read this article from the Irish Examiner

Related Articles:
Troubled Pfizer blueprints biotech venture effort. Report
Pfizer to invest $50M in biotech start-ups. Report

Suggested Articles

Life sciences companies have pivoted quickly during COVID-19 - Syneos Health® is supporting more than 80 active COVID-19 projects, including vaccines.

New York's Covaxx has signed on with three South American nations to provide 140 million doses of its early-stage COVID-19 vaccine.

To get the COVID-19 vaccine out quickly, Pfizer has been running rehearsals at distribution sites, creating "growing confidence," U.S. officials said.